Latest filing published 20 Apr 2026 for Cognition Therapeutics INC, €9,421. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Anthony Caggiano discloses dealings in Cognition Therapeutics Inc to SEC (Form 4). Between 3 February 2023 and 16 April 2026, the trades on record add up to 10 filings.
Every open-market trade on record is a purchase: 1 purchase worth €9,421, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 9 share grants. So far in 2026, the count stands at 1 purchase and no sales.
The latest filing, published on 20 April 2026, reports an open-market purchase of €9,421 in Cognition Therapeutics Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations